The size of the Diagnostic Imaging Market in the Middle East & Africa was worth USD 1.65 billion in 2022 and estimated to be growing at a CAGR of 5.94%, to reach USD 2.21 billion by 2027.
Medical imaging is the method of making a visual image of the inside of the body for therapeutic intervention. These devices aid in creating a databank of the normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.
The capability to generate pictures of a patient’s internal anatomy and alter them to film through diagnostic imaging has transformed how many diseases and injuries are spotted, diagnosed, and treated. As a result, this market has applications in several medical arenas like cardiology, neurology, and orthopedics.
The growth of the MEA Diagnostic Imaging market is mainly due to the rise in the aging population, increasing prevalence of cancer and cardiac, neurological, and musculoskeletal disorders, and rising number of diagnostic imaging techniques.
However, poor accessibility of proper care, volatile economies, and lack of awareness in this part of the world are the key factors hindering the market's growth in this region.
This research report on the MEA Diagnostic Imaging Market has been segmented and sub-segmented into the following categories:
In terms of market share, South Africa leads the market in this region. Other significant markets in this region include UAE, Israel, and Nigeria. However, the market in this region has the lowest share due to a general lack of awareness.
KEY MARKET PLAYERS:
A few of the dominating companies operating in the MEA Diagnostic Imaging Market profiled in this report are GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Hologic Inc., Fujifilm Corporation & Shimadzu Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com